In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4579-4588

  Anderson, K M ^a   Jajeh, J ^a   Guinan, P ^a,b   Rubenstein, M ^a  

^a HEKTOEN INSTITUTE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Apoptosis; DCA; HIF1A; Hypoxia; Proliferation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON DIOXIDE; DICHLOROACETIC ACID; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; NITROGEN; PYRUVATE DEHYDROGENASE;

AEROBIC CELL CULTURE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CITRIC ACID CYCLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIC CELL; IN VITRO STUDY; IN VIVO STUDY; PH; PRIORITY JOURNAL; TREATMENT FAILURE;

ADENOSINE TRIPHOSPHATE; CARBON DIOXIDE; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYGLUCOSE; DICHLOROACETATE; GLYCOLYSIS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PANCREATIC NEOPLASMS; RNA, MESSENGER;

EID: 75149145490     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 38: 1124-1144, 1989.
2. Stacpoole PW, Harman EM, Curry SH, Baumgartner TG and Misbin RI: Treatment of lactic acidosis with dichloroacetate. New Eng J Med 309: 390-396, 1983.
3. Barshop BA, Naviaux RK, McGowan KA, Levine F, Nyhan WL, Loupis-Geller A and Haas RH: Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol Genet Metab 83: 138-149, 2004
4. Kim J-W, Tchernyshyov I, Semenza GL and Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cell hypoxia. Cell Metab 3: 177-185, 2006.
5. Papandreou I, Cairns RA, Fontana L, Lim AL and Denko NC: HIF-1-mediates adaption to hypoxia by actively down-regulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
6. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth Cancer Cell 11: 37-51, 2007.
7. Schmaltz C, Harrigan Hardenbergh P, Wells A and Fisher DE: Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18: 2845-2854, 1998.
8. 2 gradients in solid tumors in vivo: High resolution measurements reveal a lack of correlation. Nat Med 3: 177-182, 1997.
9. Huang LE and Bunn HF: Hypoxia-inducible factors and its biomedical relevance. JBC 278: 19575-19578, 2003.
10. Sullivan R, Pare GC, Frederiksen LJ, Semenza GL and Graham CH: Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol Can Ther 7: 1961-1973, 2008.
11. Norris BJ, Cramer MJ and Hirschel HD: Chapt 9, Growth of cell lines in bioreactors. In: Basic Methods in Antibody Production and Characterization. Heward GC and Bethell DR (eds.). Boca Rotan FL, USA, CRC Press, 2000.
12. 2, Chemical, Biochemical and Physiologic Aspects. Forster RE, Edsall JT, Otis AB and Roughton FJW (eds.). Washington DC, NASA, 1969.
13. Lide DR (ed.). Handbook of Chemistry and Physics, 72 nd, from 6-3 to 6-7, 1991-1992. CRC Press, Boca Rotan, FL, U.S.A.
14. Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F, Wang J, Shindo M, Higashino F, Takeda K, Asaka M, Katoh H, Sugiyama T, Hosuo H and Kobayashi M: Dominant-negative hypoxia-inducible factor-1A reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Path 162: 1283-1291, 2003.
15. Wang J, Biju MP, Wang M-H, Wang M-H, Haaase VH and Dong Z: Cytoprotective effects of hypoxia against cisplatin-induced tubular cell apoptosis: Involvement of mitochondrial inhibition and p53 suppression. J Am Soc Nephrol 17: 1875-1885, 2006.
16. Hassoun EA and Mehta J: Dichloroacetate-induced modulation of cellular antioxidant enzyme activities and glutathione level in the J774A.1 cells. Appl Toxicol 28: 931-937, 2008.
17. Anderson KM, Tsui P, Guinan P and Rubenstein M: The proliferative response of HeLa cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: An analogue for studying some properties of in vivo solid cancers. Anticancer Res 26: 4155-4162, 2006.
18. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L and Koemer G: Cell death modalities: classification and pathophysiological implications. Cell Death Diff 14: 1237-1266, 2007.
19. Young SD, Marshall RS and Hill RP: Hypoxia induces DNA overreplication and enhances metaststic potential of murine tumor cells. Proc Nat Acad Sci USA 85: 9533-9537, 1988.
20. Chen Z, Odstrcil EA, Tu BP and McKnight SL: Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 316: 1916-1919, 2007.
21. Matoba S, Kang J-G, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F and Hwang PM: p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006.
22. Mizuno S, Bogaard HJ, Voelkel NF, Umeda Y, Kadowaki M, Ameshima S, Miyamori I and Ishizaki T: Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways. Resp Res 10: 17-30, 2009.
23. Kitamura N, Ota Y and Mimura K: Effects of diisopropylamine dichloroacetate on proliferation and differentiation of normal human keratinocytes in vitro. Skin Pharm Physiol 12: 317-325, 1999.
24. Murray K, Gull K and Dickson AJ: Dichloroacetate increases cell and antibody yields in hybridoma batch cultures of hybridoma cell lines. Biotech Bioeng 49: 377-382, 1996.
25. Stauberg AJ, Bull RJ and Thrall BD: Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol Appl Pharma 150: 287-294, 1998.
26. Otterson GA, Wang L, Wu X, Duan W, Gao M, Karpenko MA and Villlalona-Caiero MA: Effect of dichloroacetate in combination with chemotherapy on human lung cancer cells. J Clin Oncol 26: abstr 14637, 2008.
27. Wong JY, Huggins GS, Debidda M, Munshi NC and De Vivo I: Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol Oncol 109: 394-402, 2008.
28. Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C and Rosser CJ: Dichloroacetate (DCA) sensitizes both wild-type and overexpressing BCL-2 prostate cells in vitro to involution. Prostate 68: 1223-1236, 2008.
29. Danet GH, Pam Y, Luongo JL, Bonnet DA and Simon MC: Expansion of human SCID repopulating cells under hypoxic conditions. J Clin Res 112: 126-135, 2003.
30. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S and Comoglio PM: Hypoxia promotes invasive growth by transcription activation of the met protooncogene. Cell 3: 347-361, 2003.
31. Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW and Gores GJ: Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 42: 358-364, 2005.
32. Miyashita H, Higa K, Kato N, Kawakita T, Yoshida S, Tsubota K and Shimmura S: Hypoxia enhances the expansion of human limbel epithelial progenitor cells in vitro. Invest Opth Vis Sci 48: 3586-3593, 2007.
33. + channel a subunits in pulmonary artery smooth muscle cells. J Clin Invest 100: 2347-2353, 1997.
34. Bonnet S, D, Michelakis ED, Porter CJ, Andrade-Navarro MA,Thebaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry S, Weir EK and Archer SL: An abnormal mitochondrial hypoxia inducible factor-1A-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in Fawn hooded rats. Circulation 113: 2630-2641, 2006.
35. McMurthry MS, Bonnet S, Wu X, Wu X, Dyck JRB, Haromy A, Hashimoto K and Nichelakis ED: Dichcloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle apoptosis. Circ Res 95: 830, 2004.
36. Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Roch CJ, Ratcliffe P, Moons L, Jain RK, Collen D and Keshet E: Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.
37. + channel activity and enhances survival in vascular smooth muscle. Am J Physiol Cell Physiol 281: C157-C165, 2001.
38. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Can Res 49: 4373-4384, 1989.
39. Han X, Xi L, Wang H, Huang X, Ma X, Han Z, Wu P, Ma X, Lu Y, Wang G, Zhou J and Ma Ma: The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochem Biophys Res Commun 375: 205-209, 2008.
40. 2/M entry and transition. JBC 278: 44645-44649, 2003.
41. Izumi H, Torigoe T, Ishiguchi H, Uramoto H. Yoshida Y, Tanabe M, Tomoko I, Murakami T, Yoshida T, Nomoto M and Kohna K: Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Can Treat Rev 29: 541-549, 2009.
42. Lagadic-Gossmann D, Huc L and Lecureur V: Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Diff 11: 953-961, 2004.
43. + channel blockers. Acta Pharm Sinica 40: 644-648, 2005.
44. + channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101: 2319-2330, 1998.
45. Shieh C-C, Coghlan M, Sullivan JP and Gopalakrishnan M: Potassium channels: Molecular defects, diseases and therapeutic opportunities. Pharm Rev 52: 557-594, 2000.
46. + channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol 286: L49-L67, 2004.
47. Chiche J, Ilc K , Laferriere J, Trottier J, Dayan F, Mazure NM, Brahimi-Horn MC and Pouyssegur J: Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69: 358-368, 2009.
48. Semenza GL: Tumor metabolism: cancer cells give and take lactate. J Clin Invest 118: 3835-3837, 2008.
49. Sonveaux P,Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KN, Diepart C, Jordan BF, Kelley MJ, Gallez, Wahl ML, Feron O and Dewhirst MW: Targeting lactate-fueled respiration selectively kills hypoxic cells in mice. J Clin Invest 118: 3930-3942, 2008.
50. Galluzzo M, Pennacchietti S, Rosano S, Comoglio PM and Michielo P: Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J Clin Invest 119: 865-875, 2009.
51. Thompson CB: Metabolic enzymes as oncogenes or tumor suppressors. New Eng Med J 360: 813-814, 2009
52. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 14: 2185-2197, 2000.
53. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biomed Biocim Acta 1756: 1-24, 2005.